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Iron constitutes a major source of toxicity due to
its ability to generate reactive oxygen species that
can damage cellular macromolecules. However, the
precise mechanism by which exposure to high iron
concentrations results in cellular toxicity remains un-
known. Here we identify sphingolipid synthesis and
signaling as a major mediator of iron toxicity in
S. cerevisiae. Inhibition of sphingolipid synthesis by
myriocin treatment or after overexpression of the
negative regulator Orm2p confers resistance to
high iron. High iron conditions upregulate sphingoli-
pid synthesis, and increasing sphingolipid levels by
inactivating Orm2p exacerbates sensitivity to iron.
Toxicity is mediated by sphingolipid signaling, as
inactivation of the sphingolipid-activated protein
kinases Pkh1p and Ypk1p and of the transcription
factor Smp1p also enhances resistance to high iron
conditions. These results demonstrate an unex-
pected connection between sphingolipid flux and
iron toxicity and show that activation of a signal
transduction cascade contributes to iron-mediated
cellular toxicity.
INTRODUCTION
Iron (Fe) is a ubiquitous metal in biological systems. However, Fe
also represents a potential danger to biological macromolecules
due to its ability to generate reactive oxygen species (ROS)
(Touati, 2000; Valentine et al., 1998; Valko et al., 2005). In most
organisms, the present paradigm in Fe toxicity suggests that
themajor toxic effect of Fe is the result of the exposure of cellular
macromolecules to ROS (Touati, 2000; Valko et al., 2005).
Defects in Fe metabolism can result in various pathologies in
diseases of Fe overload (Hentze et al., 2004), underscoring the
importance of limiting iron toxicity. Thus, iron levels must be
regulated to meet the demands of cellular metabolism but also
to prevent an overabundance that might result in potential
damages. The unicellular eukaryote S. cerevisiae has been used
as a model system to study Fe transport, metabolism, and
toxicity (Philpott, 2006; Van Ho et al., 2002; Chen et al., 2002;
Lin et al., 2011). In yeast, exposure of cells to high Fe results in90 Cell Metabolism 16, 90–96, July 3, 2012 ª2012 Elsevier Inc.growth defects through inhibition of the cell cycle (Philpott
et al., 1998). Some of the protective mechanisms against Fe
toxicity include storage of iron in organelles, presumably to limit
the exposure of cytosolic or nuclear macromolecules to high iron
concentrations (Chen and Kaplan, 2000; Li et al., 2001; Lin et al.,
2011). This observation is consistent with the hypothesis that Fe
causes toxicity by oxidative damage. However, recent work has
shown that some of the toxic effects of Fe in yeast are indepen-
dent of oxidative stress (Lin et al., 2011), suggesting that the
major pathway(s) by which Fe hampers cellular growth remain
to be identified. The results presented here show that reducing
sphingolipid synthesis and signaling is sufficient to allow yeast
cells to grow in otherwise toxic iron conditions, demonstrating
that sphingolipid signaling contributes to mediating iron toxicity
in S. cerevisiae.
RESULTS
Genetic or Chemical Inhibition of Sphingolipid Synthesis
Confers Resistance to Iron Toxicity
We showed previously that yeast cells lacking the RNase III
Rnt1p are hypersensitive to high Fe (Lee et al., 2005). To further
understand the molecular basis of Fe toxicity, we performed a
high-copy suppressor screen to identify genes, which, when
overexpressed, would allow Rnt1p-deficient cells to grow in
high Fe. We constructed a genomic library from the rnt1D strain
in the multicopy vector YEp24 and performed screens in the
presence of high Fe to identify suppressors. We could not
reproducibly identify genes that allow rnt1D cells to grow in
high Fe, so we redirected our efforts to performing this screen
in wild-type cells. We isolated a clone exhibiting growth in high
Fe conditions and identified ORM2 as the gene responsible for
this effect. We confirmed that an independently cloned ver-
sion of ORM2 could confer resistance to Fe toxicity when over-
expressed in wild-type cells (Figure 1A). Orm2p and the closely
related Orm1p protein were identified as negative regulators
of sphingolipid synthesis and mediators of the endoplasmic
reticulum (ER) stress response (Breslow et al., 2010; Breslow
and Weissman, 2010; Han et al., 2010). We tested the ability
of Orm1p to confer resistance to iron toxicity and found that
ORM2-overexpressing cells (ORM2ox; pORM2 on the figures)
grew faster than ORM1ox in high Fe conditions, suggesting
that Orm2p was a more potent high copy suppressor of Fe
toxicity than Orm1p. We monitored Orm1p and Orm2p levels
in high Fe conditions, both when the proteins were HA tagged
Figure 1. ORM2 Overexpression Confers
Specific Resistance to Iron Toxicity in a
Variety of Physiological Contexts
(A) Strains were grown in SDmedium lacking uracil
(URA) supplemented with the indicated metals.
These and all subsequent assays show 10-fold
dilution series from left to right. For the bottom
panel, plates were incubated at 30C.
(B) Cells expressing Orm1p or Orm2p HA-tagged
at their chromosomal loci (Chr), transformed with
either the YEp24 vector or with plasmids con-
taining HA-tagged Orm1p or Orm2p (pORM1/2-
HA), were grown in 7 mM FeCl3, and the levels
of Orm1/2p were analyzed by immunoblot. Upper
panels are two different exposures to detect en-
dogenous and overexpressed Orm1/2p.
(C) Strains were grown on ethanol-glycerol carbon
source lacking uracil (-URAEG), without or with
5 mM FeCl3.
(D) Legends as in (A).
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HA-tagged proteins were overexpressed (Figure 1B). We found
that in this overexpression system, Orm2p was expressed
at higher levels than Orm1p in high Fe conditions (Fig-
ure 1B) and at levels much higher than the endogenous
copy. Thus, the ability of Orm2p to confer better growth in
high iron than Orm1p might be linked to higher overexpression
levels.
The resistance of ORM2ox cells to high Fe was specific to
this particular stress. In contrast to high iron, ORM2ox cells
actually grew slower than wild-type in high copper conditions
(Figure 1A). In addition, we found no growth difference
between wild-type and ORM2ox cells in high zinc (Figure 1A)
or oxidative stress conditions (Figure S1A). We also found no
differences in the levels of oxidized proteins between wild-
type and ORM2ox cells in high Fe (Figure S1B) and no growth
difference in high salt (Figure S1C) nor in survival after heat
shock (Figure S1D). Finally, because media containing high
Fe require acidic conditions in order for Fe to be soluble, we
also tested the growth of wild-type and ORM2ox cells in acidicCell Metabolism 16,medium and found no difference (Fig-
ure S1E). Thus, ORM2 overexpression
does not confer general resistance to
a variety of cellular stresses, but seems
specific to Fe toxicity.
The genetic screen identifying ORM2
was performed in glucose-containing
medium, where oxidative stress is low.
We found that overexpressing Orm2p
conferred resistance to Fe toxicity in
media containing the nonfermentable
carbon sources ethanol and glycerol (Fig-
ure 1C). Thus, Orm2p can also suppress
Fe toxicity when oxidative stress is in-
creased by respiration. To further investi-
gate the potency of the suppression of
Fe toxicity by Orm2p, we overexpressed
Orm2p in a strain deficient for the vacu-
olar Fe importer Ccc1p. Strains lack-ing Ccc1p are hypersensitive to high Fe because they cannot
store iron in the vacuole (Li et al., 2001; Lin et al., 2011). Overex-
pression of ORM2 was sufficient to rescue the growth of ccc1D
cells at 6 mM FeCl3 (Figure 1D), showing that Orm2p can also
rescue the growth of cells deficient in iron storage. Overexpress-
ing Orm1p also resulted in some suppression, although this
effect was more robust when cells were grown in medium con-
taining FeSO4 (Figure 1D). We do not fully understand why
Orm1p seems to be more potent in these conditions, but this
effect might be due to differential expression. Collectively, these
results show that overexpressing Orm1/2p can suppress Fe
toxicity in a variety of physiological contexts and can com-
pensate for defects in vacuolar iron storage. These results also
show that the capacity of Orm1/2p to suppress Fe toxicity is
not linked to their ability to influence vacuolar iron storage by
modulation of the activity of the vacuolar ATPase (Finnigan
et al., 2011), since cells lacking Ccc1p cannot store iron in the
vacuole. Taken together, these results show that overexpression
of Orm2p can suppress Fe toxicity in a variety of physiological
contexts.90–96, July 3, 2012 ª2012 Elsevier Inc. 91
Figure 2. Modulation of Sphingolipid Syn-
thesis Changes Resistance to High Iron
(A) Strains were grown on normal medium or with
the indicated concentrations of myriocin and
FeCl3.
(B) Strains were grown on normal or 6 mM FeCl3
conditions in minimal medium (SDC).
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et al., 2010), the ability of Orm2p to enhance resistance to Fe
toxicity could be attributed to two distinct pathways: (1) control
of ER stress and unfolded protein response (UPR), or (2) inhibi-
tion of sphingolipid synthesis. Since metals such as Cd can
induce the UPR (Gardarin et al., 2010), we tested whether
ORM2 confers resistance to iron toxicity by modulating the
UPR, which might have been activated by high Fe. Splicing of
the HAC1 mRNA, a hallmark of the UPR (Cox and Walter,
1996), was not triggered by growing cells in high Fe (Figure S2A),
and no differences in HAC1 splicing were found when overex-
pressing ORM2 (Figure S2A). These results show that in
contrast to Cd stress, high Fe conditions do not trigger the
UPR, and that Orm2p is unlikely to mediate resistance to high
iron by modulating ER stress. To test whether Orm2p confers
resistance to Fe toxicity by inhibiting sphingolipid synthesis,
we used the chemical inhibitor myriocin, which modulates
sphingolipid synthesis through inhibition of the long-chain
base (LCB)-synthesizing enzyme serine palmitoyltransferase
(Breslow and Weissman, 2010; Cowart and Obeid, 2007; Dick-
son et al., 2006). If ORM2 overexpression enhances resistance
to iron toxicity by inhibiting sphingolipid synthesis, exposure of
cells to subtoxic concentrations of myriocin was predicted to
have a similar protective effect. While myriocin at the concentra-
tions used had no effect on overall growth in normal medium, it
allowed wild-type cells to survive in high Fe conditions (Fig-
ure 2A). There seemed to be no cumulative effect of exposing
cells to myriocin and overexpressing ORM2, consistent with
the hypothesis that these two treatments act on the same
pathway.92 Cell Metabolism 16, 90–96, July 3, 2012 ª2012 Elsevier Inc.The previous results are consistent
with the hypothesis that ORM2 overex-
pression and myriocin treatment sup-
press iron toxicity by reducing sphingoli-
pid levels. To test whether an increase
of sphingolipid flux is toxic when com-
bined with high Fe concentrations,
we used an orm2D strain, since ORM2
inactivation was shown to upregulate
sphingolipid synthesis (Breslow et al.,
2010; Breslow and Weissman, 2010;
Finnigan et al., 2011; Han et al., 2010).
As shown in Figure 2B, cells lacking
ORM2 were unable to grow in 6 mM Fe,
while wild-type cells were still viable.
By contrast, the orm1D strain did not
exhibit any strong growth phenotype
(Figure 2B), suggesting a more promi-
nent function for Orm2p in these condi-tions. These results show that an increase of sphingolipid
synthesis confers hypersensitivity to subtoxic Fe concentra-
tions, further correlating sphingolipid flux and Fe-mediated
toxicity.
Orm2p Overexpression Does Not Reduce Cellular Iron
Levels
Since sphingolipids are integral components of membranes, the
capacity of Orm2p to enhance resistance to Fe toxicity could be
linked to a potential function in modulating the activity of a trans-
membrane Fe transporter and Fe import. To test this hypoth-
esis, we measured the iron content of wild-type and ORM2ox
cells by ICP-MS (Figure 3A). In normal Fe conditions, these
strains showed comparable low levels of Fe and of other metals
(Figure 3A). In high Fe conditions, both strains exhibited an
increase of intracellular Fe, and ORM2ox cells showed slightly
higher Fe levels than the wild-type (Figure 3A). In contrast, the
level of other metals such as Zn or Cu was similar in both strains
(Figure 3A), showing that the slightly higher Fe content in
ORM2ox cells is specific to this metal. Prior work had shown
that sphingolipids regulate the expression of Fet3p (Villa et al.,
2009), a multicopper oxidase involved in Fe transport. We
detected similar levels of the FET3 mRNA in wild-type and
ORM2ox cells (Figure S2B) in normal conditions and could not
detect FET3 in high Fe conditions in both strains, suggesting
that ORM2 overexpression in high iron does not change the
expression of this key mediator of Fe assimilation. Taken
together, these results rule out the hypothesis that Orm2p sup-
presses cellular Fe toxicity by preventing intracellular iron
uptake.
Figure 3. High Iron Conditions Result in
Higher Intracellular Iron Concentrations
and Sphingolipid LCBs
(A) Intracellular metal content analysis. Strains
were grown on SD plates containing a normal
concentration of Fe and incubated for 2 days or on
SD + 7 mM FeCl3 and incubated for 6 days
(pORM2) and 11 days (YEp24) before harvesting
for ICP-MS measurement. The results shown are
the average of six samples (triplicate samples from
two independent experiments), except for pORM2
in normal conditions, which is the average of five
samples (three and two samples from two inde-
pendent experiments).
(B) Sphingolipid analysis in normal, high Fe, and
high Cu conditions. Strains were grown either on
normal medium, 7 mM FeCl3, 200 ng/ml myriocin,
7 mM FeCl3 + 200 ng/ml myriocin, or 2 mMCuSO4
conditions and incubated at 25C until colo-
nies reached a similar size before harvesting for
LCB analysis. Triplicate samples for LCB analysis
were prepared as described in Experimental
Procedures. LCB and LCBP levels are indicated as
pmol/A600. Statistical analysis is provided in
Table S1. Evidence for reproducibility of the effect
of high iron conditions and ORM2 overexpression
on LCB levels is shown in Figure S3.
(C) Comparison of the effects of Orm1p
and Orm2p overexpression on sphingolipid levels.
Procedures were the same as in (B), except that
cells were transformed with the vector alone
(YEp24) or the vector overexpressing Orm1p or
Orm2p (pORM1/2) and grown in URA medium
(lanes 1, 2, and 3) or with URA + 7 mM FeCl3.
Shown are the average values of three in-
dependent biological samples with the standard
deviations.
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Since the previous data showed that decreasing sphingolipid
synthesis enhances the capacity to grow in high Fe, we investi-
gated whether high Fe conditions trigger an increase in sphingo-
lipid synthesis. We measured the concentration of sphingolipid
LCB and long-chain base phosphate (LCBP) metabolic interme-
diates in wild-type and ORM2ox cells, since their level is sensi-
tive to changes in growth rate and environmental stress (Cowart
and Obeid, 2007; Dickson et al., 2006). Consistent with previous
results (Breslow et al., 2010; Han et al., 2010), overexpression
of ORM2 or myriocin treatment significantly reduced LCB levels
in normal medium (Figure 3B; detailed values and statistical
analysis shown in Table S1; see also Figures S3 and S4). When
grown in high Fe, wild-type cells showed a statistically significant
increase in total LCBs and LCBPs compared to normal medium
(Figure 3B, Figure S3). These data support the hypothesis
that high Fe causes an accumulation of sphingolipid intermedi-
ates. Overexpressing Orm2p or myriocin treatment significantly
reduced LCBs in Fe-treated cells (Figure 3B, Figure S3),
and a stronger reduction was observed when combining
Orm2p overexpression and myriocin (Figure 3B, lanes 4 and 8).
Similar trends were observed for LCBPs (Figure 3B, Figure S3).
The complete analysis for each species of LCB and LCBP is
shown in Figure S4 and shows the same tendencies as total
LCBs and LCBPs. These effects were specific to Fe, as highCu was found to have no effect on LCB and LCBP levels
(Figure 3B). We also compared the ability of Orm1p and
Orm2p to modulate sphingolipid synthesis in high Fe conditions
when each of these proteins was overexpressed (Figure 3C). We
found that Orm2p overexpression conferred a statistically
significant reduction of LCBs and LCBPs in high iron com-
pared to cells transformed with the YEp24 vector (p values of
7.3 3 105 and 5.2 3 105, respectively, t test), while Orm1p
overexpression did not lead to a significant effect. These results
corroborate the suppression analysis showing that Orm2p is
a much more potent suppressor of Fe toxicity than Orm1p
(Figure 1A). Taken together, these results show that the levels
of LCB and LCBP are specifically increased in high Fe
conditions and that the capacity of Orm2p or myriocin to
enhance resistance to high Fe is correlated with a reduction in
LCB and LCBP levels.
Inactivation of Sphingolipid-Mediated Signaling
Enhances Resistance to High Iron
Ceramides have been shown to induce apoptosis in mammals
(Colombini, 2010). In addition, previous data have shown that
exposure of yeast cells to metals such as Cu and Mn can trigger
apoptosis (Liang and Zhou, 2007). Thus, the increase in sphingo-
lipid levels detected in high Fe conditionsmight potentially cause
apoptosis through an accumulation of ceramides. To test thisCell Metabolism 16, 90–96, July 3, 2012 ª2012 Elsevier Inc. 93
Figure 4. Inactivation of Sphingolipid Sig-
naling Confers Resistance to Iron Toxicity
(A) Yeast sphingolipid-mediated signal trans-
duction pathways.
(B) Strains were grown on normal minimal medium
(SDC) or SDC containing 7 mM FeCl3.
(C) Legends as in Figure 1A.
(D) Immunoblot analysis of myc-tagged Ypk1p in
normal and high iron conditions in wild-type cells
or cells overexpressing Orm2p. SDS-PAGE was
performed in the presence of 20 mM Phos-tag. To
demonstrate that the higher bands corresponded
to phospho-Ypk1p, the extracts prepared from
cells overexpressing Orm2p were treated with
lambda (l) phosphatase (PP; right lane).
(E) Legends as in (B).
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Blocking apoptosis by inactivation of the metacaspase Mca1p/
Yca1p (Madeo et al., 2002) or of the serine protease Nma111p
(Fahrenkrog et al., 2004) did not restore growth in high Fe condi-
tions (Figure 4B). We conclude that unlike Cu or Mn, high Fe is
unlikely to mediate toxicity through apoptosis.
In addition to triggering apoptosis, sphingolipids are involved
in many cellular functions, as structural components of mem-
branes, but also as signaling molecules during stress (Breslow
and Weissman, 2010; Dickson, 2008; Dickson et al., 2006). In
S. cerevisiae their signaling function is primarily mediated by
LCBs, which activate the Pkh1p and Pkh2p protein kinases (Fig-
ure 4A) (Liu et al., 2005; Roelants et al., 2002), although other
sphingolipids can act as signaling molecules as well (Roelants
et al., 2010). If the contribution of LCBs to cellular toxicity in
high iron conditions is due to their signaling function, we hypoth-
esized that strains deficient in these kinases might also exhibit
resistance to high Fe. Indeed, the pkh1D strain exhibited in-
creased resistance to high Fe (Figure 4B), while cells lacking
Pkh2p did not show this phenotype, suggesting a specific role94 Cell Metabolism 16, 90–96, July 3, 2012 ª2012 Elsevier Inc.for Pkh1p. Pkh1p has been shown to
activate several signal transduction cas-
cades (Figure 4A). To investigate which
cascade is responsible for mediating
toxicity in high iron conditions, we inacti-
vated the Mpk1p, Sch9p, Ypk1p, and
Ypk2p kinases and assessed the growth
of these mutants in high Fe. Strikingly,
inactivation of Ypk1p resulted in resis-
tance to high Fe, while none of the other
kinase knockout strains exhibited this
phenotype (Figure 4C). This suppression
phenotype is particularly striking consid-
ering that the ypk1D strain shows a
growth defect in normal medium (Fig-
ure 4C). We analyzed the expression of
some genes known to be controlled by
the Pkh1p/Ypk1p kinases, but none of
them showed a change in expression in
high iron or upon Orm2p overexpression
(Figure S2C). Thus, these kinases controlother cellular functions besides the expression of known target
genes.
To directly demonstrate that sphingolipid signaling is activated
during high Fe conditions, we assessed Ypk1p phosphorylation
by immunoblot using a strain expressing myc-tagged Ypk1p
(Figure 4D). In cells shifted to high Fe, we found increased
amounts of slower mobility forms of Ypk1p (Figure 4D). Strik-
ingly, the level of these forms was reduced upon Orm2p overex-
pression (Figure 4D). These slower mobility bands correspond to
phosphorylated forms of Ypk1p, as their mobility was increased
upon treatment of extracts with phosphatase prior to frac-
tionation (Figure 4D). This result directly shows that increased
sphingolipid levels in high iron activate the Pkh1p/Ypk1p signal
transduction cascade and that Orm2p overexpression confers
resistance to high iron by inhibiting this response and reducing
Ypk1p phosphorylation. While this work was being considered,
it was shown that Ypk1p can phosphorylate and inactivate
Orm2p (Roelants et al., 2011; Sun et al., 2012). Therefore, the
observation that Ypk1p depletion could rescue iron toxicity
might indicate that this effect could be due to Orm2p activation
Cell Metabolism
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the case, we would not expect any downstream target of Ypk1p
to have any influence on the ability of cells to grow in high iron
conditions. However, we found that inactivation of Smp1p also
rescued the ability of cells to grow in high iron conditions (Fig-
ure 4E). This result contrasts with the observation that Smp1p
inactivation usually results in decreased growth in stress condi-
tions, such as high osmolarity (de Nadal et al., 2003). In contrast,
inactivation of another transcription factor, Rlm1p, had a nega-
tive effect on growth in high iron (Figure 4E). Taken together,
these results show that sphingolipid signaling through Pkh1p,
Ypk1p, and Smp1p contributes to mediating iron toxicity.
DISCUSSION
In this study, we report the finding that genetic or chemical inhi-
bition of sphingolipid synthesis allows yeast cells to grow in
higher iron conditions, showing that sphingolipid levels are
limiting the ability of cells to grow in these conditions. We cannot
completely exclude that the increased growth of cells overex-
pressing Orm2p in high iron is due to general effects on cellular
viability, or that overexpressing Orm2p can confer resistance to
other transition metals. However the effect of Orm2p seems
specific to Fe, as overexpressing Orm2p does not confer resis-
tance to Cu or Zn or to all other stresses tested—indeed, the
opposite effect is observed for Cu, since cells overexpressing
Orm2p are more sensitive to Cu. A link between Fe levels and
sphingolipids was shown previously, as Fe deficiency was found
to reduce sphingolipids (Shakoury-Elizeh et al., 2010). This effect
might be explained by the inactivation in low iron conditions of
sphingolipid biosynthetic enzymes that require Fe as an essen-
tial cofactor. In contrast, we found that high Fe conditions
increase sphingolipid levels. This effectmight be due to a general
increase of synthesis of these lipids in response to environmental
stress, as shown previously (Liu et al., 2005). However, unlike for
other cellular stresses such as heat shock, elevated sphingoli-
pids do not confer resistance to high iron conditions, but rather
are toxic. Thus there is a unique relationship between sphingoli-
pid levels and iron-mediated cellular toxicity, as preventing upre-
gulation is sufficient to allow cells to survive in high Fe.
Our data indicate that sphingolipids mediate cellular toxicity
by acting as signaling molecules. It was shown recently that
sphingolipid signaling affects yeast life span (Huang et al.,
2012). This effect ismechanistically distinct from those described
here, as inactivation of Sch9p increases life span (Huang et al.,
2012) but decreases the ability of cells to grow in high Fe (Fig-
ure 4C). Thus, sphingolipid signaling canmodulate cellular fitness
ina variety ofmechanisms.Sphingolipid signaling throughPkh1p/
Ypk1p was shown to be required for endocytosis (deHart et al.,
2002; Friant et al., 2001), and it is known that somedivalent cation
transporters are endocytosed following exposure to high metal
concentrations (Philpott, 2006). However, our data are inconsis-
tent with the idea that these lipids play a role in limiting Fe toxicity
by controlling Fe transporter endocytosis, since we found slightly
elevated Fe levels in cells overexpressing Orm2p. Instead, sphin-
golipids play a function in mediating Fe toxicity by triggering
a change in cellular properties through the activation of the
Pkh1p/Ypk1p signal transduction cascade. Although we favor
LCBs as regulators of Pkh1p-Ypk1p signaling in high Fe, wecannot exclude that other sphingolipids are also involved, be-
cause their concentration is also affected when serine palmitoyl-
transferase activity is reduced (Breslow et al., 2010; Huang et al.,
2012). This signaling cascade involves the Smp1p transcription
factor, as Smp1p inactivation increases resistance to high Fe.
Smp1p might mediate downstream events responsible for medi-
ating Fe toxicity, which could include changes in cell cycle events
known tobeaffected inhighFe (Philpott et al., 1998). Alternatively,
other molecular events controlled by sphingolipids, such as the
activity of aminophospholipid flippases (Roelants et al., 2010),
might modify the properties of the membrane or the cell wall
and thus make the cells more sensitive to high Fe.
Iron is generally thought to mediate cellular toxicity by virtue of
its ability to generate damaging ROS (Touati, 2000; Valko et al.,
2005). By contrast, our data show that a significant part of iron
toxicity in yeast involves the activation of sphingolipid signaling.
This result is in agreement with the pioneer work from Lin and
colleagues, who showed that some of the toxic effects of
Fe are independent from oxidative stress in yeast and therefore
from the ability of Fe to generate ROS (Lin et al., 2011). Taken
together, these findings provide a paradigm change by showing
that Fe toxicity in a model eukaryotic unicellular system is
mediated, at least in part, by the activation of a biological signal
transduction cascade. It remains to be investigated if a similar
signaling pathway is activated in other eukaryotic cells exposed
to high iron conditions.
EXPERIMENTAL PROCEDURES
Strains and Plasmids
S. cerevisiae strains were derived from BMA64 (Lee et al., 2005). Genomic
library construction and screening and construction of the plasmids used in
this study are described in Supplemental Information. Cells were grown on
synthetic defined (SD) medium plates with or without specific concentrations
of added FeCl3 or FeSO4 or of other metals, as described in Supplemental
Information. Most of the growth assays were performed at 25C, unless indi-
cated otherwise in the figure legends.
Sphingolipid and Metal Analysis
Preparation of extracts for the analysis of LCB sphingolipids is described in
detail in Supplemental Information. Analysis of LCB by HPLC was performed
as described (Lester and Dickson, 2001). For measurement of metal content
by ICP-MS, cells were washed with 1 mM EDTA and water after harvesting,
before digestion with nitric acid. ICP-MS measurement was performed as
described (Kropat et al., 2011).
RNA and Protein Analysis
Protein extracts were prepared as described in Supplemental Information.
Western blot analysis of strains expressing myc-tagged Ypk1p was performed
using anti-myc polyclonal antibody. Western blot analysis of strains ex-
pressing Orm1p or Orm2p tagged at the C terminus with the HA epitope
was performed using anti-HA monoclonal antibody. Analysis of Ypk1p phos-
phorylation by phosphatase treatment and fractionation on SDS-PAGE con-
taining Phos-tag is described in Supplemental Information.
Statistical Analysis
Statistical analysis was performed using a two-tailed t test in Excel.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.cmet.2012.06.004.Cell Metabolism 16, 90–96, July 3, 2012 ª2012 Elsevier Inc. 95
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